Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury

Krithika Ramachandran, Janani Saikumar, Vanesa Bijol, Jay L. Koyner, Jing Qian, Rebecca Betensky, Sushrut S. Waikar, Vishal S. Vaidya

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Extracellular microRNAs (miRNAs) have been proposed as potentially robust and stable biomarkers of various disease conditions. The primary objective of this study was to identify miRNAs differentially occurring in the urine that could serve as potential biomarkers of acute kidney injury (AKI), because traditional AKI markers have limitations with respect to sensitivity, specificity, and timeliness of diagnosis. METHODS: We profiled 1809 miRNAs in pooled urine samples from 6 patients with AKI and from 6 healthy controls. We measured the 378 stably detectable miRNAs in the 12 samples individually and selected the top 7 miRNAs that were most different in the urine of patients with AKI compared with the non-AKI control individuals. These miRNAs were assessed in a larger cohort of patients with AKI (n = 98: 71 AKI patients in the intensive care unit (ICU) and 27 kidney transplantation patients with biopsy-proven tubular injury) and patients without AKI (n = 97: 74 healthy volunteers and 23 ICU patients without AKI). RESULTS: We identified 4 miRNAs capable of significantly differentiating patients with AKI from individuals without AKI: miR-21 (P = 0.0005), miR-200c (P < 0.0001), miR-423 (P = 0.001), and miR-4640 (P = 0.0355). The combined cross-validated area under the ROC curve for these 4 miRNAs was 0.91. The imprecision with respect to miRNA isolation and reverse transcription efficiency was <9% across 224 samples. CONCLUSIONS: In this study we determined the entire miRNome of human urine and identified a panel of miRNAs that are both detectable noninvasively and diagnostically sensitive indicators of kidney damage.

Original languageEnglish (US)
Pages (from-to)1742-1752
Number of pages11
JournalClinical Chemistry
Volume59
Issue number12
DOIs
StatePublished - Dec 1 2013

Fingerprint

MicroRNAs
Acute Kidney Injury
Urine
Kidney
Wounds and Injuries
Intensive care units
Biomarkers
Intensive Care Units
Biopsy
Transcription
ROC Curve
Kidney Transplantation
Reverse Transcription
Area Under Curve
Healthy Volunteers
Sensitivity and Specificity

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. / Ramachandran, Krithika; Saikumar, Janani; Bijol, Vanesa; Koyner, Jay L.; Qian, Jing; Betensky, Rebecca; Waikar, Sushrut S.; Vaidya, Vishal S.

In: Clinical Chemistry, Vol. 59, No. 12, 01.12.2013, p. 1742-1752.

Research output: Contribution to journalArticle

Ramachandran, K, Saikumar, J, Bijol, V, Koyner, JL, Qian, J, Betensky, R, Waikar, SS & Vaidya, VS 2013, 'Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury', Clinical Chemistry, vol. 59, no. 12, pp. 1742-1752. https://doi.org/10.1373/clinchem.2013.210245
Ramachandran, Krithika ; Saikumar, Janani ; Bijol, Vanesa ; Koyner, Jay L. ; Qian, Jing ; Betensky, Rebecca ; Waikar, Sushrut S. ; Vaidya, Vishal S. / Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. In: Clinical Chemistry. 2013 ; Vol. 59, No. 12. pp. 1742-1752.
@article{660b252373ff462d8d8719eb6bac56d5,
title = "Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury",
abstract = "BACKGROUND: Extracellular microRNAs (miRNAs) have been proposed as potentially robust and stable biomarkers of various disease conditions. The primary objective of this study was to identify miRNAs differentially occurring in the urine that could serve as potential biomarkers of acute kidney injury (AKI), because traditional AKI markers have limitations with respect to sensitivity, specificity, and timeliness of diagnosis. METHODS: We profiled 1809 miRNAs in pooled urine samples from 6 patients with AKI and from 6 healthy controls. We measured the 378 stably detectable miRNAs in the 12 samples individually and selected the top 7 miRNAs that were most different in the urine of patients with AKI compared with the non-AKI control individuals. These miRNAs were assessed in a larger cohort of patients with AKI (n = 98: 71 AKI patients in the intensive care unit (ICU) and 27 kidney transplantation patients with biopsy-proven tubular injury) and patients without AKI (n = 97: 74 healthy volunteers and 23 ICU patients without AKI). RESULTS: We identified 4 miRNAs capable of significantly differentiating patients with AKI from individuals without AKI: miR-21 (P = 0.0005), miR-200c (P < 0.0001), miR-423 (P = 0.001), and miR-4640 (P = 0.0355). The combined cross-validated area under the ROC curve for these 4 miRNAs was 0.91. The imprecision with respect to miRNA isolation and reverse transcription efficiency was <9{\%} across 224 samples. CONCLUSIONS: In this study we determined the entire miRNome of human urine and identified a panel of miRNAs that are both detectable noninvasively and diagnostically sensitive indicators of kidney damage.",
author = "Krithika Ramachandran and Janani Saikumar and Vanesa Bijol and Koyner, {Jay L.} and Jing Qian and Rebecca Betensky and Waikar, {Sushrut S.} and Vaidya, {Vishal S.}",
year = "2013",
month = "12",
day = "1",
doi = "10.1373/clinchem.2013.210245",
language = "English (US)",
volume = "59",
pages = "1742--1752",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "12",

}

TY - JOUR

T1 - Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury

AU - Ramachandran, Krithika

AU - Saikumar, Janani

AU - Bijol, Vanesa

AU - Koyner, Jay L.

AU - Qian, Jing

AU - Betensky, Rebecca

AU - Waikar, Sushrut S.

AU - Vaidya, Vishal S.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - BACKGROUND: Extracellular microRNAs (miRNAs) have been proposed as potentially robust and stable biomarkers of various disease conditions. The primary objective of this study was to identify miRNAs differentially occurring in the urine that could serve as potential biomarkers of acute kidney injury (AKI), because traditional AKI markers have limitations with respect to sensitivity, specificity, and timeliness of diagnosis. METHODS: We profiled 1809 miRNAs in pooled urine samples from 6 patients with AKI and from 6 healthy controls. We measured the 378 stably detectable miRNAs in the 12 samples individually and selected the top 7 miRNAs that were most different in the urine of patients with AKI compared with the non-AKI control individuals. These miRNAs were assessed in a larger cohort of patients with AKI (n = 98: 71 AKI patients in the intensive care unit (ICU) and 27 kidney transplantation patients with biopsy-proven tubular injury) and patients without AKI (n = 97: 74 healthy volunteers and 23 ICU patients without AKI). RESULTS: We identified 4 miRNAs capable of significantly differentiating patients with AKI from individuals without AKI: miR-21 (P = 0.0005), miR-200c (P < 0.0001), miR-423 (P = 0.001), and miR-4640 (P = 0.0355). The combined cross-validated area under the ROC curve for these 4 miRNAs was 0.91. The imprecision with respect to miRNA isolation and reverse transcription efficiency was <9% across 224 samples. CONCLUSIONS: In this study we determined the entire miRNome of human urine and identified a panel of miRNAs that are both detectable noninvasively and diagnostically sensitive indicators of kidney damage.

AB - BACKGROUND: Extracellular microRNAs (miRNAs) have been proposed as potentially robust and stable biomarkers of various disease conditions. The primary objective of this study was to identify miRNAs differentially occurring in the urine that could serve as potential biomarkers of acute kidney injury (AKI), because traditional AKI markers have limitations with respect to sensitivity, specificity, and timeliness of diagnosis. METHODS: We profiled 1809 miRNAs in pooled urine samples from 6 patients with AKI and from 6 healthy controls. We measured the 378 stably detectable miRNAs in the 12 samples individually and selected the top 7 miRNAs that were most different in the urine of patients with AKI compared with the non-AKI control individuals. These miRNAs were assessed in a larger cohort of patients with AKI (n = 98: 71 AKI patients in the intensive care unit (ICU) and 27 kidney transplantation patients with biopsy-proven tubular injury) and patients without AKI (n = 97: 74 healthy volunteers and 23 ICU patients without AKI). RESULTS: We identified 4 miRNAs capable of significantly differentiating patients with AKI from individuals without AKI: miR-21 (P = 0.0005), miR-200c (P < 0.0001), miR-423 (P = 0.001), and miR-4640 (P = 0.0355). The combined cross-validated area under the ROC curve for these 4 miRNAs was 0.91. The imprecision with respect to miRNA isolation and reverse transcription efficiency was <9% across 224 samples. CONCLUSIONS: In this study we determined the entire miRNome of human urine and identified a panel of miRNAs that are both detectable noninvasively and diagnostically sensitive indicators of kidney damage.

UR - http://www.scopus.com/inward/record.url?scp=84889825012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889825012&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2013.210245

DO - 10.1373/clinchem.2013.210245

M3 - Article

VL - 59

SP - 1742

EP - 1752

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 12

ER -